|
|
|
Volumn 61, Issue 8, 2003, Pages 1381-1387
|
|
Newer disease--modifying drugs: glatiramer acetate and mitoxantrone
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLATIRAMER;
IMMUNOSUPPRESSIVE AGENT;
MITOXANTRONE;
PEPTIDE;
CENTRAL NERVOUS SYSTEM;
CLINICAL TRIAL;
HUMAN;
IMMUNOLOGY;
INTRAVENOUS DRUG ADMINISTRATION;
MULTIPLE SCLEROSIS;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
T LYMPHOCYTE;
TH2 CELL;
CENTRAL NERVOUS SYSTEM;
CLINICAL TRIALS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
MITOXANTRONE;
MULTIPLE SCLEROSIS;
PEPTIDES;
T-LYMPHOCYTES;
TH2 CELLS;
|
|
EID: 0142124712
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (17)
|
